Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Anti-Infective Therapy market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Anti-Infective Therapy market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Penicillin Sulphonamides Aminoglycosides Fluoroquinolones Antifungals Antiprotozoal Others Segmented by End User/Segment Home User Hospitals/Clinics Ambulatory Surgery Centres Others Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey WOCKHARDT Sun Pharmaceutical Industries Limited Sanofi Ranbaxy Laboratories Limited Pfizer, Inc. Panacea Biotec Limited Novartis AG Merck Lupin Limited Johnson & Johnson Glenmark Pharmaceuticals Limited GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) F. Hoffmann-La Roche Ltd Cipla Ltd. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) AstraZeneca plc Abbott Laboratories Ltd.

List of Figures

Figure Anti-Infective Therapy Picture
Figure Global Anti-Infective Therapy Sales Volume and Growth Rate (2016-2027)
Figure Global Anti-Infective Therapy Sales Value and Growth Rate (2016-2027)
Figure Global Anti-Infective Therapy Sales Value CAGR (2020-2027) by Region
Figure Global Anti-Infective Therapy Sales Volume Market Share by Company, 2020
Figure Global Anti-Infective Therapy Sales Value Market Share by Company, 2020
Figure Global Anti-Infective Therapy Sales Value and Growth Rate (2016-2027)
Figure Product Picture of Penicillin
Figure Product Picture of Sulphonamides
Figure Product Picture of Aminoglycosides
Figure Product Picture of Fluoroquinolones
Figure Product Picture of Antifungals
Figure Product Picture of Antiprotozoal
Figure Product Picture of Others
Figure Global Anti-Infective Therapy Sales Volume Market Share by Category, 2020
Figure Global Anti-Infective Therapy Sales Value Market Share by Category, 2020
Figure North America Anti-Infective Therapy Sales Volume Market Share by Category, 2020
Figure Europe Anti-Infective Therapy Sales Volume Market Share by Category, 2020
Figure Asia Pacific Anti-Infective Therapy Sales Volume Market Share by Category, 2020
Figure Central & South America Anti-Infective Therapy Sales Volume Market Share by Category, 2020
Figure Middle East & Africa Anti-Infective Therapy Sales Volume Market Share by Category, 2020
Figure Anti-Infective Therapy in Home User
Figure Global Anti-Infective Therapy Market: Home User (2016-2021)
Figure Anti-Infective Therapy in Hospitals/Clinics
Figure Global Anti-Infective Therapy Market: Hospitals/Clinics (2016-2021)
Figure Anti-Infective Therapy in Ambulatory Surgery Centres
Figure Global Anti-Infective Therapy Market: Ambulatory Surgery Centres (2016-2021)
Figure Anti-Infective Therapy in Others
Figure Global Anti-Infective Therapy Market: Others (2016-2021)
Figure Global Anti-Infective Therapy Sales Volume Market Share by End User/Segment, 2020
Figure Global Anti-Infective Therapy Sales Value Market Share by End User/Segment, 2020
Figure North America Anti-Infective Therapy Sales Volume Market Share by End User/Segment, 2020
Figure Europe Anti-Infective Therapy Sales Volume Market Share by End User/Segment, 2020
Figure Asia Pacific Anti-Infective Therapy Sales Volume Market Share by End User/Segment, 2020
Figure Central & South America Anti-Infective Therapy Sales Volume Market Share by End User/Segment, 2020
Figure Middle East & Africa Anti-Infective Therapy Sales Volume Market Share by End User/Segment, 2020
Figure Global Anti-Infective Therapy Sales Volume Market Share by Region (2016-2021)
Figure Global Anti-Infective Therapy Sales Value Market Share by Region (2016-2021)
Figure North America Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure North America Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Europe Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Europe Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Asia Pacific Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure North America Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Central & South America Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Europe Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Middle East & Africa Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure China Anti-Infective Therapy Sales Value Status (2016-2021)
Figure North America Anti-Infective Therapy Sales Volume Market Share by Country, 2020
Figure Japan Anti-Infective Therapy Sales Value Status (2016-2021)
Figure United States Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Asia Other Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Canada Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Canada Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Mexico Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Mexico Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Europe Anti-Infective Therapy Sales Volume Market Share by Country, 2020
Figure Europe Anti-Infective Therapy Value Market Share by Country, 2020
Figure Germany Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Germany Anti-Infective Therapy Sales Value Status (2016-2021)
Figure France Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure France Anti-Infective Therapy Sales Value Status (2016-2021)
Figure UK Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure UK Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Italy Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Italy Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Russia Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Russia Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Spain Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Spain Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Asia Pacific Anti-Infective Therapy Sales Volume Market Share by Country, 2020
Figure Asia Pacific Anti-Infective Therapy Value Market Share by Country, 2020
Figure China Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure China Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Japan Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Japan Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Korea Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Korea Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Southeast Asia Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Southeast Asia Anti-Infective Therapy Sales Value Status (2016-2021)
Figure India Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure India Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Australasia Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Australasia Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Central & South America Anti-Infective Therapy Sales Volume Market Share by Country, 2020
Figure Central & South America Anti-Infective Therapy Sales Value Market Share by Country, 2020
Figure Brazil Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Brazil Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Argentina Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Argentina Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Colombia Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Colombia Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Middle East & Africa Anti-Infective Therapy Sales Volume Market Share by Country, 2020
Figure Middle East & Africa Anti-Infective Therapy Value Market Share by Country, 2020
Figure Iran Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Iran Anti-Infective Therapy Sales Value Status (2016-2021)
Figure South Africa Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure South Africa Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Israel Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Israel Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Turkey Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Turkey Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Saudi Arabia Anti-Infective Therapy Sales Volume Status (2016-2021)
Figure Saudi Arabia Anti-Infective Therapy Sales Value Status (2016-2021)
Figure Anti-Infective Therapy Supply Chain Analysis
Figure Anti-Infective Therapy Production Process Chart Analysis
Figure Anti-Infective Therapy Manufacturing Cost Analysis
Figure Global Anti-Infective Therapy Sales Volume Forecast (2022-2027)
Figure Global Anti-Infective Therapy Sales Value Forecast (2022-2027)
Figure North America Anti-Infective Therapy Sales Volume Forecast (2022-2027)
Figure North America Anti-Infective Therapy Sales Value Forecast (2022-2027)
Figure Global Anti-Infective Therapy Sales Value Growth Rate Forecast (2022-2027)
Figure Europe Anti-Infective Therapy Sales Value Forecast (2022-2027)
Figure Asia Pacific Anti-Infective Therapy Sales Volume Forecast (2022-2027)
Figure North America Anti-Infective Therapy Sales Value Forecast (2022-2027)
Figure Central & South America Anti-Infective Therapy Sales Volume Forecast (2022-2027)
Figure Europe Anti-Infective Therapy Sales Value Forecast (2022-2027)
Figure Middle East & Africa Anti-Infective Therapy Sales Volume Forecast (2022-2027)
Figure China Anti-Infective Therapy Sales Value Forecast (2022-2027)
Figure Japan Anti-Infective Therapy Sales Value Forecast (2022-2027)
Figure Asia Other Anti-Infective Therapy Sales Value Forecast (2022-2027)
Figure WOCKHARDT Anti-Infective Therapy Sales Volume Market Share Globally (2019-2021)
Figure WOCKHARDT Anti-Infective Therapy Sales Value Market Share Globally (2019-2021)
Figure Sun Pharmaceutical Industries Limited Anti-Infective Therapy Sales Volume Market Share Globally (2019-2021)
Figure Sun Pharmaceutical Industries Limited Anti-Infective Therapy Sales Value Market Share Globally (2019-2021)
Figure Sanofi Anti-Infective Therapy Sales Volume Market Share Globally (2019-2021)
Figure Sanofi Anti-Infective Therapy Sales Value Market Share Globally (2019-2021)
Figure Ranbaxy Laboratories Limited Anti-Infective Therapy Sales Volume Market Share Globally (2019-2021)
Figure Ranbaxy Laboratories Limited Anti-Infective Therapy Sales Value Market Share Globally (2019-2021)
Figure Pfizer, Inc. Anti-Infective Therapy Sales Volume Market Share Globally (2019-2021)
Figure Pfizer, Inc. Anti-Infective Therapy Sales Value Market Share Globally (2019-2021)
Figure Panacea Biotec Limited Anti-Infective Therapy Sales Volume Market Share Globally (2019-2021)
Figure Panacea Biotec Limited Anti-Infective Therapy Sales Value Market Share Globally (2019-2021)
Figure Novartis AG Anti-Infective Therapy Sales Volume Market Share Globally (2019-2021)
Figure Novartis AG Anti-Infective Therapy Sales Value Market Share Globally (2019-2021)
Figure Merck Anti-Infective Therapy Sales Volume Market Share Globally (2019-2021)
Figure Merck Anti-Infective Therapy Sales Value Market Share Globally (2019-2021)
Figure Lupin Limited Anti-Infective Therapy Sales Volume Market Share Globally (2019-2021)
Figure Lupin Limited Anti-Infective Therapy Sales Value Market Share Globally (2019-2021)
Figure Johnson & Johnson Anti-Infective Therapy Sales Volume Market Share Globally (2019-2021)
Figure Johnson & Johnson Anti-Infective Therapy Sales Value Market Share Globally (2019-2021)

Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Anti-Infective Therapy Market Status and Forecast (2016-2027) 1.3.2 Global Anti-Infective Therapy Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Anti-Infective Therapy Supply by Company 2.1 Global Anti-Infective Therapy Sales Volume by Company 2.2 Global Anti-Infective Therapy Sales Value by Company 2.3 Global Anti-Infective Therapy Price by Company 2.4 Anti-Infective Therapy Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional Anti-Infective Therapy Market Status by Category 3.1 Anti-Infective Therapy Category Introduction 3.1.1 Penicillin 3.1.2 Sulphonamides 3.1.3 Aminoglycosides 3.1.4 Fluoroquinolones 3.1.5 Antifungals 3.1.6 Antiprotozoal 3.1.7 Others 3.2 Global Anti-Infective Therapy Market by Category 3.2.1 Global Anti-Infective Therapy Sales Volume by Category (2016-2021) 3.2.2 Global Anti-Infective Therapy Sales Value by Category (2016-2021) 3.2.3 Global Anti-Infective Therapy Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Anti-Infective Therapy Market Status by End User/Segment 4.1 Anti-Infective Therapy Segment by End User/Segment 4.1.1 Home User 4.1.2 Hospitals/Clinics 4.1.3 Ambulatory Surgery Centres 4.1.4 Others 4.2 Global Anti-Infective Therapy Market by End User/Segment 4.2.1 Global Anti-Infective Therapy Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Anti-Infective Therapy Sales Value by End User/Segment (2016-2021) 4.2.3 Global Anti-Infective Therapy Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Anti-Infective Therapy Market Status by Region 5.1 Global Anti-Infective Therapy Market by Region 5.1.1 Global Anti-Infective Therapy Sales Volume by Region 5.1.2 Global Anti-Infective Therapy Sales Value by Region 5.2 North America Anti-Infective Therapy Market Status 5.3 Europe Anti-Infective Therapy Market Status 5.4 Asia Pacific Anti-Infective Therapy Market Status 5.5 Central & South America Anti-Infective Therapy Market Status 5.6 Middle East & Africa Anti-Infective Therapy Market Status6 North America Anti-Infective Therapy Market Status 6.1 North America Anti-Infective Therapy Market by Country 6.1.1 North America Anti-Infective Therapy Sales Volume by Country (2016-2021) 6.1.2 North America Anti-Infective Therapy Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Anti-Infective Therapy Market Status 7.1 Europe Anti-Infective Therapy Market by Country 7.1.1 Europe Anti-Infective Therapy Sales Volume by Country (2016-2021) 7.1.2 Europe Anti-Infective Therapy Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Anti-Infective Therapy Market Status 8.1 Asia Pacific Anti-Infective Therapy Market by Country 8.1.1 Asia Pacific Anti-Infective Therapy Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Anti-Infective Therapy Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Anti-Infective Therapy Market Status 9.1 Central & South America Anti-Infective Therapy Market by Country 9.1.1 Central & South America Anti-Infective Therapy Sales Volume by Country (2016-2021) 9.1.2 Central & South America Anti-Infective Therapy Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Anti-Infective Therapy Market Status 10.1 Middle East & Africa Anti-Infective Therapy Market by Country 10.1.1 Middle East & Africa Anti-Infective Therapy Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Anti-Infective Therapy Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Anti-Infective Therapy Manufacturing Cost Analysis 11.5 Anti-Infective Therapy Sales Channel and Distributors Analysis 11.5.1 Anti-Infective Therapy Sales Channel 11.5.2 Anti-Infective Therapy Distributors 11.6 Anti-Infective Therapy Downstream Major Buyers12 Global Anti-Infective Therapy Market Forecast by Category and by End User/Segment 12.1 Global Anti-Infective Therapy Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Anti-Infective Therapy Forecast by Category 12.2.1 Global Anti-Infective Therapy Sales Volume Forecast by Category 12.2.2 Global Anti-Infective Therapy Sales Value Forecast by Category 12.2.3 Global Anti-Infective Therapy Price Forecast by Category 12.3 Global Anti-Infective Therapy Forecast by End User/Segment 12.3.1 Global Anti-Infective Therapy Sales Volume Forecast by End User/Segment 12.3.2 Global Anti-Infective Therapy Sales Value Forecast by End User/Segment 12.3.3 Global Anti-Infective Therapy Price Forecast by End User/Segment13 Global Anti-Infective Therapy Market Forecast by Region/Country 13.1 Global Anti-Infective Therapy Market Forecast by Region (2022-2027) 13.1.1 Global Anti-Infective Therapy Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Anti-Infective Therapy Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 WOCKHARDT 14.1.1 Company Information 14.1.2 Anti-Infective Therapy Product Introduction 14.1.3 WOCKHARDT Anti-Infective Therapy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Sun Pharmaceutical Industries Limited 14.2.1 Company Information 14.2.2 Anti-Infective Therapy Product Introduction 14.2.3 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Sanofi 14.3.1 Company Information 14.3.2 Anti-Infective Therapy Product Introduction 14.3.3 Sanofi Anti-Infective Therapy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Ranbaxy Laboratories Limited 14.4.1 Company Information 14.4.2 Anti-Infective Therapy Product Introduction 14.4.3 Ranbaxy Laboratories Limited Anti-Infective Therapy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Pfizer, Inc. 14.5.1 Company Information 14.5.2 Anti-Infective Therapy Product Introduction 14.5.3 Pfizer, Inc. Anti-Infective Therapy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Panacea Biotec Limited 14.6.1 Company Information 14.6.2 Anti-Infective Therapy Product Introduction 14.6.3 Panacea Biotec Limited Anti-Infective Therapy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Novartis AG 14.7.1 Company Information 14.7.2 Anti-Infective Therapy Product Introduction 14.7.3 Novartis AG Anti-Infective Therapy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 Merck 14.8.1 Company Information 14.8.2 Anti-Infective Therapy Product Introduction 14.8.3 Merck Anti-Infective Therapy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 Lupin Limited 14.9.1 Company Information 14.9.2 Anti-Infective Therapy Product Introduction 14.9.3 Lupin Limited Anti-Infective Therapy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Johnson & Johnson 14.10.1 Company Information 14.10.2 Anti-Infective Therapy Product Introduction 14.10.3 Johnson & Johnson Anti-Infective Therapy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis 14.11 Glenmark Pharmaceuticals Limited 14.12 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) 14.13 F. Hoffmann-La Roche Ltd 14.14 Cipla Ltd. 14.15 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) 14.16 AstraZeneca plc 14.17 Abbott Laboratories Ltd.15 Conclusion16 Methodology